VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Brookfield Infrastructure Partners L.P. vs Gilead Sciences, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Brookfield Infrastructure Partners L.P.
BIP · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Brookfield Infrastructure Partners L.P.'s moat claims, evidence, and risks.
View BIP analysisGilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisComparison highlights
- Moat score: both at 74 / 100.
- Segment focus: Brookfield Infrastructure Partners L.P. has 4 segments; Gilead Sciences, Inc. has 5 segments (68.5% in HIV).
- Primary market structure: Quasi-Monopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Brookfield Infrastructure Partners L.P. has 4 moat types across 3 domains; Gilead Sciences, Inc. has 8 across 3.
Primary market context
Brookfield Infrastructure Partners L.P.
Utilities
Regulated and contracted utility infrastructure (electric transmission, gas pipelines/distribution, metering and residential energy services)
Global
Regulators and contracted counterparties; residential and commercial end-users via utility networks
Owner-operator of regulated networks and contracted utility assets
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Brookfield Infrastructure Partners L.P. strengths
Gilead Sciences, Inc. strengths
Segment mix
Brookfield Infrastructure Partners L.P. segments
Full profile >Utilities
Quasi-Monopoly
Transport
Oligopoly
Midstream
Oligopoly
Data
Oligopoly
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.